HOME › DRUGS › RALTEGRAVIR POTASSIUM
ACTIVE SUBSTANCE / INN

RALTEGRAVIR POTASSIUM

Brand name(s): DUTREBIS, ISENTRESS HD, RALTEGRAVIR POTASSIUM, Raltegravir Viatris, ISENTRESS
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
HIV Infections
ANDA217990
ACTIVE SUBSTANCE
Raltegravir Potassium
REGULATORS
FDA · EMA
SPONSORS / MAH
LUPIN LTD, HETERO LABS LTD III, Viatris Limited
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DUTREBISNDA206510MERCK SHARP DOHMEDiscontinued
ISENTRESSNDA203045MSD SUB MERCKPrescription
RALTEGRAVIR POTASSIUMANDA217990LUPIN LTDPrescription
ISENTRESS HDNDA022145MSD SUB MERCKPrescription
RALTEGRAVIR POTASSIUMANDA203540HETERO LABS LTD IIIDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Raltegravir ViatrisViatris LimitedApplication withdrawnHIV Infections

FULL INTELLIGENCE ON RALTEGRAVIR POTASSIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →